Circassia Pharmaceuticals (GB:NIOX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
NIOX Group PLC has successfully completed its tender offer, purchasing 26.25 million ordinary shares at 80 pence each, returning approximately £21 million to shareholders. This move, involving significant shareholders like Harwood Capital and AstraZeneca, is deemed a related party transaction but is considered fair by independent directors. Post-tender, the company will have 397.88 million shares with voting rights, providing a new baseline for shareholder interest calculations.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.
